Company DescriptionTranscend Medical, Inc. is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020. The Transcend Medical approach is focused on replacing the current therapies for the treatment of glaucoma with a less invasive procedure and minimal complications.

Proceeds PurposesTranscend will use the funds for development of additional infrastructure and resources for its U.S. pivotal study of the CyPass Micro-Stent, (www.CompassClinicalStudy.com), as well as for ongoing international clinical trials and development of next generation glaucoma solutions.